Vor Biopharma Inc.
VOR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$813 | -$1,574 | -$32 | -$31 |
| Dep. & Amort. | $0 | $2 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $2 | $2 |
| Change in WC | $5 | $5 | -$3 | $3 |
| Other Non-Cash | $754 | $1,532 | $1 | $1 |
| Operating Cash Flow | -$54 | -$35 | -$31 | -$24 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $1 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | -$0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | $1 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $22 | $175 | -$1 | $56 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | -$0 | -$2 |
| Financing Cash Flow | $22 | $175 | -$1 | $53 |
| Forex Effect | -$0 | $2 | $0 | $0 |
| Net Chg. in Cash | -$33 | $143 | -$32 | $29 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $193 | $50 | $84 | $55 |
| End Cash | $160 | $193 | $52 | $84 |
| Free Cash Flow | -$54 | -$35 | -$31 | -$24 |